Literature DB >> 26905229

Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma.

Felix J Hüttner1, Christina Fitzmaurice, Guido Schwarzer, Christoph M Seiler, Gerd Antes, Markus W Büchler, Markus K Diener.   

Abstract

BACKGROUND: Pancreatic cancer is the fourth-leading cause of cancer death for both, men and women. The standard treatment for resectable tumours consists of a classic Whipple (CW) operation or a pylorus-preserving pancreaticoduodenectomy (PPW). It is unclear which of these procedures is more favourable in terms of survival, postoperative mortality, complications, and quality of life.
OBJECTIVES: The objective of this systematic review was to compare the effectiveness of CW and PPW techniques for surgical treatment of cancer of the pancreatic head and the periampullary region. SEARCH
METHODS: We conducted searches on 28 March 2006, 11 January 2011, 9 January 2014, and 18 August 2015 to identify all randomised controlled trials (RCTs), while applying no language restrictions. We searched the following electronic databases on 18 August 2015: the Cochrane Central Register of Controlled Trials (CENTRAL), the Cochrane Database of Systematic Reviews (CDSR) and the Database of Abstracts of Reviews of Effects (DARE) from the Cochrane Library (2015, Issue 8); MEDLINE (1946 to August 2015); and EMBASE (1980 to August 2015). We also searched abstracts from Digestive Disease Week and United European Gastroenterology Week (1995 to 2010); we did not update this part of the search for the 2014 and 2015 updates because the prior searches did not contribute any additional information. We identified two additional trials through the updated search in 2015. SELECTION CRITERIA: RCTs comparing CW versus PPW including participants with periampullary or pancreatic carcinoma. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted data from the included trials. We used a random-effects model for pooling data. We compared binary outcomes using odds ratios (ORs), pooled continuous outcomes using mean differences (MDs), and used hazard ratios (HRs) for meta-analysis of survival. Two review authors independently evaluated the methodological quality and risk of bias of included trials according to the standards of The Cochrane Collaboration. MAIN
RESULTS: We included eight RCTs with a total of 512 participants. Our critical appraisal revealed vast heterogeneity with respect to methodological quality and outcome parameters. Postoperative mortality (OR 0.64, 95% confidence interval (CI) 0.26 to 1.54; P = 0.32), overall survival (HR 0.84, 95% CI 0.61 to 1.16; P = 0.29), and morbidity showed no significant differences, except of delayed gastric emptying, which significantly favoured CW (OR 3.03, 95% CI 1.05 to 8.70; P = 0.04). Furthermore, we noted that operating time (MD -45.22 minutes, 95% CI -74.67 to -15.78; P = 0.003), intraoperative blood loss (MD -0.32 L, 95% CI -0.62 to -0.03; P = 0.03), and red blood cell transfusion (MD -0.47 units, 95% CI -0.86 to -0.07; P = 0.02) were significantly reduced in the PPW group. All significant results were associated with low-quality evidence based on GRADE (Grades of Recommendation, Assessment, Development and Evaluation) criteria. AUTHORS'
CONCLUSIONS: Current evidence suggests no relevant differences in mortality, morbidity, and survival between the two operations. However, some perioperative outcome measures significantly favour the PPW procedure. Given obvious clinical and methodological heterogeneity, future high-quality RCTs of complex surgical interventions based on well-defined outcome parameters are required.

Entities:  

Mesh:

Year:  2016        PMID: 26905229      PMCID: PMC8255094          DOI: 10.1002/14651858.CD006053.pub6

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  68 in total

1.  Two thousand consecutive pancreaticoduodenectomies.

Authors:  John L Cameron; Jin He
Journal:  J Am Coll Surg       Date:  2015-01-06       Impact factor: 6.113

2.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

3.  [Surgical palliation of pancreatic carcinoma. Results of a 7 year period].

Authors:  T C Koslowsky; J Wilke; W Voiss; S Michaelis; D Balta; M Siedek
Journal:  Chirurg       Date:  2001-06       Impact factor: 0.955

4.  Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.

Authors:  J P Neoptolemos; D D Stocken; J A Dunn; J Almond; H G Beger; P Pederzoli; C Bassi; C Dervenis; L Fernandez-Cruz; F Lacaine; J Buckels; M Deakin; F A Adab; R Sutton; C Imrie; I Ihse; T Tihanyi; A Olah; S Pedrazzoli; D Spooner; D J Kerr; H Friess; M W Büchler
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

5.  A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy.

Authors:  M F Brennan; P W Pisters; M Posner; O Quesada; M Shike
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

6.  Are there indications for palliative resection in pancreatic cancer?

Authors:  D J Gouma; E J Nieveen van Dijkum; R C van Geenen; T M van Gulik; H Obertop
Journal:  World J Surg       Date:  1999-09       Impact factor: 3.352

7.  Complications after pancreaticoduodenectomy: the problem of current definitions.

Authors:  Giovanni Butturini; Stefano Marcucci; Enrico Molinari; Giuseppe Mascetta; Luca Landoni; Stefano Crippa; Claudio Bassi
Journal:  J Hepatobiliary Pancreat Surg       Date:  2006

8.  Role of somatostatin in the prevention of pancreatic stump-related morbidity following elective pancreaticoduodenectomy in high-risk patients and elimination of surgeon-related factors: prospective, randomized, controlled trial.

Authors:  Yan-Shen Shan; Edgar D Sy; Pin-Wen Lin
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

Review 9.  A comparison of pancreaticoduodenectomy with pylorus preserving pancreaticoduodenectomy: a meta-analysis of 2822 patients.

Authors:  N Iqbal; R E Lovegrove; H S Tilney; A T Abraham; S Bhattacharya; P P Tekkis; H M Kocher
Journal:  Eur J Surg Oncol       Date:  2008-02-01       Impact factor: 4.424

10.  Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.

Authors:  Betsy A Kohler; Recinda L Sherman; Nadia Howlader; Ahmedin Jemal; A Blythe Ryerson; Kevin A Henry; Francis P Boscoe; Kathleen A Cronin; Andrew Lake; Anne-Michelle Noone; S Jane Henley; Christie R Eheman; Robert N Anderson; Lynne Penberthy
Journal:  J Natl Cancer Inst       Date:  2015-03-30       Impact factor: 13.506

View more
  37 in total

1.  [Robotic pylorus-preserving pancreaticoduodenectomy : Video article].

Authors:  H Aselmann; J Hendrik Egberts; J Henrik Beckmann; H Stein; C Schafmayer; S Hinz; B Reichert; T Becker
Journal:  Chirurg       Date:  2017-05       Impact factor: 0.955

Review 2.  [R1 resection for pancreatic carcinoma].

Authors:  G F Weber; S Kersting; F Haller; R Grützmann
Journal:  Chirurg       Date:  2017-09       Impact factor: 0.955

3.  Pancreaticoduodenectomy for pediatric and adolescent pancreatic malignancy: A single-center retrospective analysis.

Authors:  Erika B Lindholm; Abdulaziz K Alkattan; Sara J Abramson; Anita P Price; Todd E Heaton; Vinod P Balachandran; Michael P La Quaglia
Journal:  J Pediatr Surg       Date:  2016-11-16       Impact factor: 2.545

Review 4.  Optimal literature search for systematic reviews in surgery.

Authors:  Käthe Goossen; Solveig Tenckhoff; Pascal Probst; Kathrin Grummich; André L Mihaljevic; Markus W Büchler; Markus K Diener
Journal:  Langenbecks Arch Surg       Date:  2017-12-05       Impact factor: 3.445

Review 5.  Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis.

Authors:  Pipit Burasakarn; Ryota Higuchi; Souya Nunobe; Shingo Kanaji; Hidetoshi Eguchi; Ken-Ichi Okada; Tsutomu Fujii; Yuichi Nagakawa; Kengo Kanetaka; Hiroharu Yamashita; Suguru Yamada; Shinji Kuroda; Toru Aoyama; Takahiro Akahori; Kenji Nakagawa; Masakazu Yamamoto; Hiroki Yamaue; Masayuki Sho; Yasuhiro Kodera
Journal:  Int J Clin Oncol       Date:  2021-01-01       Impact factor: 3.402

Review 6.  Pylorus preservation pancreatectomy or not.

Authors:  Ulla Klaiber; Pascal Probst; Markus W Büchler; Thilo Hackert
Journal:  Transl Gastroenterol Hepatol       Date:  2017-12-04

7.  Mortality after pancreaticoduodenectomy: assessing early and late causes of patient death.

Authors:  Sowmya Narayanan; Allison N Martin; Florence E Turrentine; Todd W Bauer; Reid B Adams; Victor M Zaydfudim
Journal:  J Surg Res       Date:  2018-06-27       Impact factor: 2.192

8.  Indications, technique, and results of robotic pancreatoduodenectomy.

Authors:  Niccolò Napoli; Emanuele F Kauffmann; Francesca Menonna; Vittorio Grazio Perrone; Stefania Brozzetti; Ugo Boggi
Journal:  Updates Surg       Date:  2016-09-10

Review 9.  Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy.

Authors:  Yao Cheng; Marta Briarava; Mingliang Lai; Xiaomei Wang; Bing Tu; Nansheng Cheng; Jianping Gong; Yuhong Yuan; Pierluigi Pilati; Simone Mocellin
Journal:  Cochrane Database Syst Rev       Date:  2017-09-12

10.  Percutaneous irreversible electroporation with systemic treatment for locally advanced pancreatic adenocarcinoma.

Authors:  Edward Leen; John Picard; Justin Stebbing; Mark Abel; Tony Dhillon; Harpreet Wasan
Journal:  J Gastrointest Oncol       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.